• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TRP
Click for more information
11.6% 38.0¢

TISSUE REPAIR LTD - Charts / Financials

Market Cap $22.97M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company... Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company developing second generation wound healing agents. The Company's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The Company is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.53pm 26/07/2024 (20 minute delay) ?
Day
Open 40.0¢   Day High 42.0¢   Day Low 35.0¢
Daily Volume 2389707
Bids   Sellers
Number Price Volume   Number Price Volume
1 37.0¢ 74487   1 38.0¢ 1426

Directors & Senior Management

Mr. Tony Charara Co-Founder, Executive Director
Mr. Cameron Jones Chief Financial Officer
Dr. Darryl Reed Chief Operating Officer
Mr. William Bost Vice President - Manufacturing
Dr. Pramod Nednoor Vice President - Chemistry and Controls
Mr. Mark Waring Vice President - Clinical and Regulatory Affairs
Ms. Sushma Kejriwal Company Secretary
Mr. Jack Lowenstein Independent Non-Executive Chairman of the Board
Dr. Michael Silberberg Non-Executive Director
Mr. Bryan Gray Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
38.0¢ 		Change
-0.050(11.6%) 		Mkt cap ! $22.97M
Open High Low Value Volume
40.0¢ 42.0¢ 35.0¢ $929.9K 2.389M

Buyers (Bids)

No. Vol. Price($)
1 74487 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 1426 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
Last
37.5¢ 		  Change
-0.050 ( 11.4 %)
Open High Low Volume
40.0¢ 42.0¢ 35.0¢ 492955
Last updated 15.53pm 26/07/2024 ?

Top Stories

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Monadelphous (ASX:MND) has flagged its receipt of a $200M contract with Woodside Energy (ASX:WDS).
MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned MinRes (ASX:MIN) shares jumped 5% nearly right out the gate on Friday following an update from the miner it’s on track to meet FY24 production guidance.The already $50+ stock jumped 5%, perhaps surprising, if a cynic wanted to bring iron ore prices into it. The steelmaking commodi...
Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision Horizon Minerals (ASX:HRZ) has announced its independent ore reserve for Boorara, flagging 49.5Koz of gold production over a 14mth LOM.The company expects the project to fetch just short of $20M.All permits are in place, haulage contracts are @well advanced” and an ore sales...
Nine's staff strike as Paris Olympic coverage begins Paris is off to a rocky start, with Australia's beloved Matildas going down 3-0 to Germany overnight, five water polo stars being struck by Covid, and if that's not enough to dull the excitement, Nine Entertainment Co Holdings (ASX:NEC) sent reporters to Paris only to have some of its unionised team go on strike in a fight for better pay.
Tissue Repairs soars nearly 32% on TGA approval for wound healing gel Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic Goods Administration) approval for its advanced wound healing gel TR Pro+, which contains yeast-derived active ingredient Glucoprime.At 13:25 AEDT, shares in Tissue Repai...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.